Available online on 15.11.2022 at http://jddtonline.info

Journal of Drug Delivery and Therapeutics

Open Access to Pharmaceutical and Medical Research

Copyright  © 2022 The  Author(s): This is an open-access article distributed under the terms of the CC BY-NC 4.0 which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided the original author and source are credited

Open Access   Full Text Article                                                                                                                                                                              Review Article 

Concept and Management of Diffuse Hair Loss (Intithār al-Sha‘r) in the light of Unani medicine: A Review

Farzana Akhter1* M. A. Quamri2, Nasir Yousf3

PG. Scholar, Department of Amraz-e-Jild-wa-Tazeeniyat, National Institute of Unani Medicine, Kottigepalya, Magadi Main Road, Bengaluru, 560091, Karnataka 

HOD, Department of Amraz-e-Jild-wa-Tazeeniyat, National Institute of Unani Medicine, Kottigepalya, Magadi Main Road, Bengaluru, 560091, Karnataka

PG. Scholar, Department of Amraz-e-Jild-wa-Tazeeniyat, National Institute of Unani Medicine, Kottigepalya, Magadi Main Road, Bengaluru, 560091, Karnataka 

Article Info:

_______________________________________________

Article History:

Received 03 Sep 2022      

Reviewed 19 Oct 2022

Accepted 02 Nov 2022  

Published 15 Nov 2022  

_______________________________________________

Cite this article as: 

Akhter F, Quamri MA, Yousf N, Concept and Management of Diffuse Hair Loss (Intithār al-Sha‘r) in the light of Unani medicine: A Review, Journal of Drug Delivery and Therapeutics. 2022; 12(6):205-209

DOI: http://dx.doi.org/10.22270/jddt.v12i6.5790              _______________________________________________

*Address for Correspondence:  

Farzana Akhter, PG. Scholar, Department of Amraz-e-Jild-wa-Tazeeniyat, National Institute of Unani Medicine, Kottigepalya, Magadi Main Road, Bengaluru, 560091, Karnataka 

Abstract

___________________________________________________________________________________________________________________

Diffuse Hair loss (DHL) is an excessive loss of hair from all over the scalp without producing any bald spots, inflammation or scarring. It is the result of disruption of one phase of the hair cycle. According to Unani system, the term used is Intithār al-Sha‘r. Various Unani scholars like Dioscorides, Ibn MāswayhZakariyyā RāzīAli Ibn Abbas Al-MajūsīIbn Sīnā described Intithār al-Sha‘r in detail with its etiopathogenesis and management in their treatises. They stated that the most common cause is poor production of bukhārāt-i-dukhānīyya, leads to poor gathering in the masamaat (Skin pores), thus, producing yābusat in the whole body. This yābusat alter the normal structure of body’s skin, make it extremely thin and loose. So, hair comes out easily when gently pulled, resulting in hair thinning and shedding. The purpose of this review is to highlight the concept of Diffuse Hair Loss in Unani system with its treatment as mentioned in classical Unani books.

Keywords: Diffuse Hair Loss, Intithār al-Sha‘r, bukhārāt-i-dukhānīyya, Unani scholars,

 


 

Introduction 

The most common DHL is telogen effluvium(TE)It is a condition in which the anagen phase of the hair cycle is prematurely terminated, resulting in diffuse club hair loss. It is common throughout the world, affecting both sexes, but shows women preponderance.1,2 It can be acute TE, chronic TE or chronic diffuse telogen hair loss. Fever or medical conditions are the most prevalent triggers, as these stimuli induce hair follicles to prematurely change from anagen to telogen. Excessive hair shedding occurs approximately 3 months after the telogen phase ends. About 100-1000 per day shedding of hair is noted.3,4 In Unani system of medicine, hair loss or hair fall is described under the heading of Intithār al-Sha‘r.The Intithār is an Arabic word, which has several meanings, one of them is falling of leaves from a tree, while Sha‘r is also Arabic word used for hair.6,7 Collectively, both words represent an appropriate term for hair fall. In modern system, there is no specific treatment for it. However, corticosteroids and innovative cosmetic therapies including Stemoxydine and CNPDA (Caffeine, niacinamide, panthenol, dimethicone, and acrylate polymer) have been reported, but their efficacies remain unestablished. So, there is a need to explore alternative therapies for its treatment.8,9

Epidemiology:

Due to the preclinical nature of the disease, the true incidence or prevalence of telogen effluvium is unknown. It has no racial predilection and affects both males and females, with females having a greater incidence rate, because women present more frequently with this complaint, as they tend to find hair shedding more distressful than men and thus, women seek more medical attention. 1,3,4

Pathophysiology3,4,8-10 

When a large number of hair follicles in the anagen phase are stimulated to stop growing prematurely, TE develops. The fraction of hair entering the catagen, followed by the telogen, rises as a result of this. Excessive hair shedding occurs about two to three months after triggering events. There are five functional changes in the hair cycle, according to Headington, that could lead to more telogen hair shedding.

  1. Immediate anagen release: It is the most common change in the hair cycle where triggers like high fever cause the follicle to prematurely shift from anagen to telogen.
  2. Delayed anagen release: Observed in a postpartum state. Due to estrogen hormone, hair remains in an extended anagen phase during pregnancy and leads to a very full head of hair. However, following delivery, a low estrogen level shifts anagen hair to the telogen phase and produces hair loss.

  3. Short anagen syndrome: It is an idiopathic shortening of the anagen phase that results in persistent telogen hair loss. This is the underlying mechanism for the majority of cases with chronic telogen effluvium.

  4. Immediate telogen release: This is due to the telogen phase shortening, which causes a huge discharge of club hair mainly due to drugs like minoxidil. 

  5. Delayed telogen release: This is due to a prolonged telogen phase and a delayed transition to the anagen phase, which is thought to be the cause of human seasonal hair loss.

To understand the pathogenesis of Intithār al-Sha‘r, first it is to understand the physiology of Sha‘r, which is  discussed under three headings:

  1. Composition of Bukhārāt-i- dukhānīyya (hair substance):  

Sha‘r comes under A’dā ̕ Mufrada according to Abul Hasan Bin Abbas and Abū Suhal Masīhī.11  It is produced by bukhārāt-i- dukhānīyya of the body which is expelled towards the skin by tabī ̒at.  Bukhārāt-i- dukhānīyya is an end product of the 3rd and 4th phases of food digestion (Hadm ̒ Udwī wa ̒ Urūqī).12 It is formed up of the words bukhār and dukhān. Bukhār is made up of ajzā mā ̕ iyya and ajzā hawāyya, whereas, Dukhān is made up of ajzā ardiyya and ajzā nāriyya.13

  1. Formation of Sha‘r:

Initially, the badani harārat isolates the bukhārāt-i-dukhānīyya from the akhlāt. then, these isolated bukhārāt are shifted towards the skin by tabī ̒at. In the skin pores, ajzā mā ̕ iyya of bukhārāt-i- dukhānīyya is affected by badani harārat, which causes it to escape through pores (masamaat) while leaving other ajzā unaffected. By frequent supply of bukhārāt-i- dukhānīyya from the akhlāt, the unaffected ajzā is driven out of the skin pores with some part remaining inside the pores, resulting in the formation of hair.12-16 This is similar to the hair follicle and hair shaft. The purpose behind the formation of hair is to provide protection and beautification. The mizāj of Sha‘r is hārr Yābis and is one of the factors among the ten criteria of Ajnās-i- mizāj.13,16

  1.  Factors regulates the formation and growth of Sha‘r:12-17

1. It's important to have abundance of blood because more blood means more dukhān, which is the substance of hair.

2. Blood thickening is vital because if it thickens, the dukhān that forms from it will thicken as well, allowing its constituents to cling together. In contrast, if blood is thin, the components of mā ̕ iyya will be more and their components will be unable to stick together.

3. Mizāj of the body should be hārr because strong harārat will produce more dukhān, this is the reason why hair grows less in cold temperaments.

4. It is important to keep the body moderate in rutūbat wa yābusat because increased rutūbat causes scalp skin pores to constrict, whereas increased yābusat causes scalp skin pores to expand, disturbing normal hair production because bukhārāt-i- dukhānīyya cannot assemble properly and emerge from scalp skin pores as hair.

5. Skin Pores orifice should be an average in terms of narrowing and dilatation, because dilatation of pores causes abnormal stagnation of bukhārāt-i- dukhānīyya, whereas, narrowing prevents these bukhārāt from penetrating the pores and preventing them from emerging as hair.

In the nutshell, the harārat (body and bukhārāt-i- dukhānīyya) acts on the stored bukhārāt in the masamaat until more bukhārāt-i- dukhānīyya comes, pushing these bukhārāt from the masamaat as in the form of hair. This detachment and contemplation of bukhārāt-i- dukhānīyya in the masamaat is cyclic.13,14 This cycle may disrupt due to poor production of hair mādda or defects in masamaat or dū ̒ fal harārat, thus resulting in Intithār al-Sha‘r.

According to Akbar ArzānīIbn Hubal BaghdadiAli Ibn Abbas Al- Majūsī and various others considered several etiological factors for Intithār al-Sha‘r. 15,18-23

  1.  Alteration in Ghidhā (nutrients/ Mādda) causes a defect in the formation of bukhārāt-i- dukhānīyya, the main substance of hair formation leads to loss of hair, seen in Sū ̕al-qinya, Sil wa Diq (TB and Pthiasis)
  2. Mutkhalkhul-jild causes abnormal dilatation of pores (masamaat), results in poor stagnation of bukhārāt-i-dukhānīyya in the pores, which makes hair thin and fall easily.  
  3. Dryness and compactness of the skin (khuskhi wa kasafat-e-jild) lead to constriction of pores, resulting in poor gathering of bukhārāt-i- dukhānīyya in the pores, which makes hair curly and during plucking, hair does not come out from the skin easily.

But according to Ibn Sīnā and Ismail Jurjānī, Intithār al-Sha‘r happens due to two reason, primarily due to defect in mādda, which is further associated with three conditions viz are12,24

  1. Poor production of bukhārāt-i- dukhānīyya mainly due to medical illnesses, e.g Sil wa Diq, 
  2. Reduced production of bukhārāt-i- dukhānīyya as seen in women and children

iii. Taghayyur in bukhārāt-i- dukhānīyya, 

Secondarily due to Defect in Masamaat which is further associated with;12,24

  1. Abnormal dilation of pores, resulting in altered mādda stagnation
  2. Narrowing of pores, impeding mādda penetration
  3. Mādda degradation in scalp skin pores

Poor production of bukhārāt-i-dukhānīyya due to medical illnesses is the most prevalent cause of Intithār al-Sha‘r, leading to poor accumulation of bukhārāt-i- dukhānīyya in the masamaat. The medical illnesses alter the mizāj, by producing yābusat in whole body. This yābusat alter the normal structure of body’s skin, make it extremely thin and loose. So, hair comes out easily when gently pulled, resulting in hair thinning and shedding. 

Diagnosis 

Diagnosis of Diffuse Hair Loss (DHL) in general and in particularly about telogen effluvium is thoroughly based on medical history, followed by clinical examination and certain basic investigations. A detailed history on the occurrence of specific triggering events are beneficial. Accordingly, the scalp and hair examination can be carried out in three different methods:1,4,9,25 

Non-invasive Method: 

General examination: On inspection, the scalp is normal with no signs of inflammation or widening of the central part. Bitemporal recession may be noticed in some cases. 

Hair Pull Test:  This test is used to determine hair cycle disturbances. Near the scalp, a collection of around 60 hair is gathered between the thumb and forefingers of the hand. Gentle traction is performed away from the scalp in a steady, progressive motion. A hair of less than six or 10% indicates normal shedding, indicating a negative test, but a hair of more than six or 10% indicates active hair shedding, indicating a positive test. Shampooing should be avoided for at least 24 hours before a pull test. This test is carried out on all areas of the scalp (vertex and scalp margins). In both acute and chronic TE, the test is positive from all areas of the scalp. 1,4,9,25,26  

Trichoscopy: It is the term used for dermoscopic imaging of scalp and hair. In a healthy scalp, it shows follicular units containing 2-4 terminal hair and 1 or 2 vellus hair of uniform thickness and color. In Telogen effluvium, trichoscopy is a diagnosis of exclusion. It shows empty hair follicles, absence of hair shaft variation and peripilar halo with the presence of upright regrowing hair. 9,27

Phototrichogram: This is a simpler, more reproducible and sensitive technique than classical trichogram and is used to assess the rate of hair growth, hair density and rate of shedding. All hairs within 2 sq cm area are trimmed 1 mm from the skin surface and a baseline photograph is taken. This process of trimming and photograph is repeated, until enough pictures are available for comparison.25,26,28

Semi-invasive Methods: 

Trichogram or Hair pluck test: This test is used for hair cycle disturbances.  In this test, 40-60 hairs are plucked with rubber- armed forcep and examining them under a microscope. It provides information about the state of proximal end of hair shaft and anagen: telogen ratio. In case of telogen effluvium, there is significant decrease in the anagen: telogen ratio with about 15% to 25% are telogen hair. 9, 25,29

Invasive Methods: 

Scalp Biopsy: This technique is used to differentiate chronic TE from female pattern hair loss and diffuse alopecia areata. In this test, two 4mm punch biopsies from the vertex of the scalp are taken with vertical and horizontal sectioning. This test mainly assesses the terminal and vellus count and anagen: telogen ratio. In chronic TE, there is increased telogen hair as compared to anagen hair with an anagen: telogen ratio of 8:1 compared to 14:1 on normal scalp biopsy. 1,4,9,25,26  

Blood tests:

To rule out an underlying cause, a comprehensive blood count including red blood cell indices, iron studies, thyroid function test, syphilis serology, serum zinc and antinuclear antibody should be performed. 1,3,4, 9,25

Treatment

The main component of management is educating the patient about the disease's natural history and course. It is necessary to discuss the normal hair cycle as well as the relationship between triggers and the onset of hair loss. The patient can be reassured that they are unlikely to go bald. Regrowth can be noted 3-6 months after the trigger has been removed.1,3,4

It does not have a specific treatment. But based on the pathophysiology, various possible treatment methods can be used to reduce hair shaft shedding.

There are currently no FDA-approved catagen inhibitors or anagen inducers in the market. Catagen-inducing medicines including beta-blockers, retinoids, anticoagulants and antithyroid therapies should be avoided while catagen-inducing endocrine diseases such thyroid dysfunction, hyperandrogenism and hyperprolactinemia should be treated concurrently. Catagen-promoting deficiencies such as iron, zinc, estrogen or proteins can also be treated with substitution therapy.  In case of iron deficiency anemia, iron supplementation should be continued for 3-6 months until iron stores are replenished.26

Besides, many new cosmetic treatments for hair thinning like Stemoxydine and CNPDA (Caffeine, niacinamide, panthenol, dimethicone and acrylate polymerhave been reported. CNPDA is the most effective treatment, as it increases 10% cross-sectional area of individual terminal hair. Though, efficacies remain to be unestablished.8,9

Usoole ̒ Ilāj and ̒ Ilāj: 

Usoole ̒ Ilāj is based on removing the cause, followed by Ta ̒dīl mizāj through tadbīr or Ghidhā and use of advia with particular qualities of Muqawwī Dimāgh, Quwwat Qābiḍa, Quwwat Jādhibā, Latīf harārat, Muqawwī wa Muṣawwīd Sha‘r, Munbit-i-Sha‘r and Taṭwīl al-Sha‘r.

The ̒ Ilāj of Intithār al-Sha‘r depends upon the cause;

  1. Defective mādda: The treatment approaches utilized to correct it is Ilāj bi’l-Tadbīr (Regimental therapy) wa ̒ Ilāj bi'l Ghidhā (Dietotherapy) and ̒ Ilāj bi'l Dawā (Pharmacotherapy)

i) ̒ Ilāj bi’l- Tadbīr 12,15,18,19,21,24

ii)  ̒ Ilāj   bi’l  Ghidhā12,15,18,19,21,24

iii)  ̒ Ilāj bi’l-Dawa 12,15,18,19,21,24

Following compound formulations have been mentioned in classical books such as

 i) ̒ Ilāj bi’l- Tadbīr:  It is done by Hammām Mu ̒tadil 12,15,18,19,21,24

ii)  ̒ Ilāj bi’l-Dawā: 12,15,18,19,21,24,30

Tilā ̕ (Liniment): Use of Qabiz (Astringent), Jādhib (Absorptive) and Muqawwi (Tonic) drugs e.g  

Oral:  Muqawwī Dimāgh (Brain Tonic) drugs like Itrifal Ustukhudoos, Itrifal Sagheer, Itrifal Muqawwī Dimāgh 

  1. khuskhi wa kasafat-e-jild (Compactness and dryness of skin): The treatment approaches utilized to correct it is Ilāj bi’l-Tadbīr (Regimental therapy) wa ̒ Ilāj bi'l Ghidhā (Dietotherapy) and ̒ Ilāj bi'l Dawā (Pharmacotherapy) 

i)  ̒ Ilāj bi’l- Tadbīr: 12,15,18,19,21,24 

ii)  ̒ Ilāj bi’l Ghidhā: 12,15,18,19,21,24

 Use Ghidhā that produces harārat (Heat) e.g Siyah mirch (Piper nigrum), Darchini (Cinnamomum zeyanicum)

iii)  ̒ Ilāj bi’l-Dawā: 12,15,18,19,21,24

 Tilā ̕ (Liniment):  Use following drugs as tilā ̕ on scalp to open the masamaat (skin pores) such as:

Conclusion 

Intithār al-Sha‘r mainly occurs due to the defect in the mādda, masamaat or harārat resulting in hair thinning and shedding. Despite the availability of a number of therapies in conventional medicine comprises corticosteroids, stemoxydine, CNPDA (Caffeine, niacinamide, panthenol, dimethicone, and acrylate polymer) still their efficacies are not upto the mark.  Evidently, Unani scholar claims that they have successfully controlled conditions like Intithar al Shar without any adverse effects for a very long period of time. The treatment is based on the properties of Muqawwī Dimāgh (Brain tonic), Quwwat Qābiḍa (Astringent)Quwwat Jādhibā (Absorptive), Latīf harārat Muqawwī wa Muṣawwīd Sha‘r (Hair tonic) Munbit-i-Sha‘r (Hair grower) and Taṭwīl al-Sha‘r (Hair elongator). Therefore, the efficacy and outcomes of different treatment modalities described in text should further be evaluated and validated by randomized clinical trial

References

1. Harrison S, Bergfeld W. Diffuse hair loss: its triggers and management. Cleve Clin J Med. 2009 Jun; 76(6):361-7. https://doi.org/10.3949/ccjm.76a.08080

2. Malkud S. A Hospital-based Study to Determine Causes of Diffuse Hair Loss in Women. J Clin Diagn Res. 2015 Aug; 9(8):WC01-4 https://doi.org/10.7860/JCDR/2015/14089.6170

3. Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K. Fitzpatrick's Dermatology in General Medicine. Vol 1. 8th ed. United States: McGraw-Hill Companies; 2012:960-990

4. Griffiths C, Cox N, Breathnach S, Burns T. Rook's Textbook of Dermatology. Vol 4. 8th ed. UK: Wiley-Blackwell; 2010: 66.1-66.7

5. Standard medical Unani Terminology. New Delhi: CCRUM (AYUSH); 2012:281

6. Sina I. Al Qanoon fil Tibb (Arabic Lughat). Jamia Hamdard: Dehli Jadeed Hind; 1998:25

7. https://www.almaany.com/ar/dict/ar-ar/%D8%A7%D9%86%D8%AA%D8%AB%D8%A7%D8%B1

8. Asghar et al. Telogen effluvium. A Review of the Literature. Cureus 2020; 12(5): e8320 https://doi.org/10.7759/cureus.8320

9. Liyanage D, Sinclair R. Telogen Effluvium. Cosmetics 2016; 3,13 https://doi.org/10.3390/cosmetics3020013

10. Sams MW, lynch P. Principles and Practice of Dermatology. 2nd ed. Churchill Livingstone; 1996: 788-789

11. Hamdani HK. Usool-e-Tib. New Dehli. 2006:70

12. Sina I. Al Qanoon fil Tibb (Urdu translation by Kantoori GH). Vol 4. New Delhi: Idara Kitabul Shifa; YNM; 2010: 34:1407-1410

13. Nafees B. Tarjuma wa Sharah Kulliyate Nafeesi (Urdu Translation by M Kabeeruddin). New Delhi:Idarae Kitabul Shifa; 1954: 58, 269-271

14. Galen. Kitab-Fi-Al-Mizaj. (Edited & translated by Zillur Rahman HS). Aligarh: International Printing press; 2008:143-148

15. Majoosi AHABA. Kamil-ul-Sana'a (Urdu translation by Kantoori GH). Vol 2. New Delhi: Idara Kitabul Shifa; 2010:110-112, 255

16. Qamri AMH. Ghina Muna (Urdu translation Minhajul Ilaj). New Delhi: CCRUM; 2008:431-440

17. Tabari AHABSR. Firdous al-Hikmat (Urdu translation by Hakeem MA Shah). New Delhi: Idara Kiatabul Shifa; 2010:56-60

18. Baghdadi IH. Al Mukhtaraat Fi al-Tibb (Urdu translation by CCRUM). Vol 4. New Delhi: CCRUM, Ministry of Health and Family Welfare, Govt. of India; 2007: 99-100, 106

19. Arzani A. Tibbe Akbar. Deoband: Faisal Publications; YNM: 743-744

20. Razi ABMBZ. Al Hawi (Urdu Translation by CCRUM). Part 1, Vol 23. New Delhi: CCRUM, Ministry of Health and Family Welfare, Govt. of India; 2007:174-187

21. Razi ABMBZ. Kitab ul Fakhir Fil Tibb (Urdu Translation by CCRUM). New Delhi: CCRUM, Ministry of Health and Family Welfare, Govt. of India; 2008: 9-10

22. Qarshi HMH. Jami-ul-Hikmat. New Delhi: Idara Kitabul Shifa; 2011: 1013-114

23. Kabeeruddin M. Moalijat Shara Asbab. New Delhi: Idara Kitabul Shifa; 2009:353-355

24. Jurjani AH. Zakhira Khawarizam Shahi (Urdu translation by Khan HH). Vol 9. New Delhi: Idara Kitabul Shifa; 2010: 3-6

25. Mubki et al. Evaluation and diagnosis of the hair loss patient: Part I. History and clinical examination Journal of the American Academy of Dermatology 2014; 71(3): 415.e1-415.e15 https://doi.org/10.1016/j.jaad.2014.04.070

26. Grover C, Khurana A. Telogen effluvium. Indian J Dermatol Venereol Leprol 2013; 79:591-603 https://doi.org/10.4103/0378-6323.116731

27. Nilam, J.; Bhavana, D. Trichoscopy in alopecias: Diagnosis simplified. Int. J. Trichol 2013; 4: 170-178 https://doi.org/10.4103/0974-7753.130385

28. Dhurat R, Saraogi P. Hair evaluation methods: merits and demerits. Int J Trichology. 2009 Jul; 1(2):108-19 https://doi.org/10.4103/0974-7753.58553

29. Shrivastava SB, Sagar V. A study of Non-Scarring Diffuse Alopecia. Journal of Advance Research in Medicine 2018; 5(2):13-18 https://doi.org/10.24321/2349.7181.201808

30. Al Masihi QI. Kitab Al Umda Fil Jarahat. (Urdu translation by CCRUM). Vol 1. New Delhi: CCRUM. 96-99